At the last check on Friday, Cellebrite DI Ltd.’s (NASDAQ:CLBT) stock was up $0.13, moving up 1.60 percent to $8.18. The average number of shares traded per day over the past five days has been 550,278 shares. 5 times new highs have been achieved over the past 5 days, with a $0.48 gain in that time frame. In the last twenty days, the average volume was 489,379, while in the previous 50 days, it was 384,406.
Since last month, CLBT stock rose 10.68%. Shares of the company fell to $7.13 on 08/03/23, the lowest level in the past month. A 52-week high of $8.15 was reached on 09/01/23 after having rallying from a 52-week low of $3.80. Since the beginning of this year, CLBT’s stock price has risen by 87.59% or $3.81, and marked a new high 28 times. However, the stock has increased by 0.36% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
The stock’s beta is 1.29. Besides these, the trailing price-to-sales (P/S) ratio of 5.40, the price-to-book (PB) ratio of 90.88, and the price-to-cash flow ratio of 27.74 may also be considered.
Financial Health
In the three months ended June 29, Cellebrite DI Ltd.’s quick ratio stood at 1.60, while its current ratio was 1.60, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 82.30% percent. In the year ended June 29, EBITDA margin amounted to 4.51%, whereas operating margins totaled 4.50%. Based on annual data, CLBT earned $219.91 million in gross profit and brought in $270.65 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 1.50%. Return on equity (ROE) for the past 12 months was -95.60%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CLBT’s revenue rose 9.02% during the quarter, while net income inched up to $270.65 million. While analysts expected Cellebrite DI Ltd. to report $0.02 quarterly earnings, the actual figure was $0.05 per share. During the quarter, the company generated $6.9 million in EBITDA. The liabilities of Cellebrite DI Ltd. were 408.34 million at the end of its most recent quarter ended June 29, and its total debt was $13.59 million.
Technical Picture
This quick technical analysis looks at Cellebrite DI Ltd.’s (CLBT) price momentum. With a historical volatility rate of 23.28%, the RSI 9-day stood at 69.84% on 31 August.
With respect to its five-day moving average, the current Cellebrite DI Ltd. price is up by +6.24% percent or $0.48. At present, CLBT shares trade +10.55% above its 20-day simple moving average and +46.15% percent above its 100-day simple moving average. However, the stock is currently trading approximately +28.86% above its SMA50 and +68.45% above its SMA200.
Stochastic coefficient K was 95.82% and Stochastic coefficient D was 89.09%, while ATR was 0.24. Given the Stochastic reading of 98.80% for the 14-day period, the RSI (14) reading has been calculated as 64.54%. As of today, the MACD Oscillator reading stands at 0.25, while the 14-day reading stands at 0.34.
